Candel Therapeutics Inc — Quarterly Cash Flow (NASDAQ:CADL) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Total assets 21.52 M106.87 M95.91 M105.97 M93.6 M Total liabilities 36.77 M40.54 M21.23 M15.76 M13.47 M Total equity 15.26 M66.33 M74.67 M90.21 M80.12 M Total liabilities & shareholders' equities 21.52 M106.87 M95.91 M105.97 M93.6 M Total debt ————— Net debt —————

ニュース

Paul Manning acquista azioni Candel Therapeutics (CADL) per 3 mln $

Le azioni Candel Therapeutics calano dopo il pricing dell’offerta da 100 milioni di dollari

Candel Therapeutics stock falls on $100 million offering pricing

Why Is Candel Therapeutics Stock Falling Friday? - Candel Therapeutics (NASDAQ:CADL)

New Strong Sell Stocks for January 20th

Diamond Hill Investment Group, Rhythm Pharmaceuticals, Vail Resorts And Other Big Stocks Moving Higher On Thursday - Candel Therapeutics (NASDAQ:CADL), Centene (NYSE:CNC)

Obiettivo di prezzo di Candel Therapeutics alzato a $14 da Freedom Capital

Candel Therapeutics stock price target raised to $14 by Freedom Capital

Candel Therapeutics to present phase 3 prostate cancer trial data at SITC

EXCLUSIVE: Trinity Capital's New Loan Fuels Bobbie's Mission To Set New US Infant Nutrition Standards - Trinity Cap (NASDAQ:TRIN)

Candel Therapeutics secures $130 million term loan facility

Candel Therapeutics Has A Protracted, But Real, Timeline To Approval Now